Nexavar 200 mg/1
sorafenib · TABLET, FILM COATED · Bayer HealthCare Pharmaceuticals Inc.
Nexavar (sorafenib) is an oral kinase inhibitor tablet used to treat certain types of cancer, including liver cancer, kidney cancer, and thyroid cancer. This prescription medication works by blocking proteins that help cancer cells grow and divide.
Key Facts
- Brand Name
- Nexavar
- Generic Name
- sorafenib
- NDC Code (Product)
50419-488- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA021923
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 12/20/2005
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Nexavar used for?
Nexavar (sorafenib) is an oral kinase inhibitor tablet used to treat certain types of cancer, including liver cancer, kidney cancer, and thyroid cancer. This prescription medication works by blocking proteins that help cancer cells grow and divide.
Is Nexavar a controlled substance?
Nexavar is not classified as a controlled substance by the DEA.
What is the generic name for Nexavar?
The generic name for Nexavar is sorafenib. There are 7 other brand versions of sorafenib.
What is the NDC code for Nexavar 200 mg/1?
The NDC (National Drug Code) for Nexavar 200 mg/1 is 50419-488, listed by Bayer HealthCare Pharmaceuticals Inc..